1.
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 1 : februari 2021
2.
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium in August 2021 : brief communication on preliminary results of the SCOPE study
3.
4.
5.
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 2 : april 2021
Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
Pre-vaccination SARS-CoV-2 seroprevalence among staff and residents of nursing homes in Flanders (Belgium) in fall 2020
6.
7.
8.
Vaccine hesitancy towards the COVID-19 vaccine in a random national sample of Belgian nursing home staff members
Declining prevalence of SARS-CoV-2 antibodies among vaccinated nursing home residents and staff six months after the primary BNT162b2 vaccination campaign in Belgium : a prospectiv...
Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.